Squadron Capital Management LLC
CIK 2050709 · Holdings on Jun 30, 2026 · First reported Aug 14, 2026
Top ten holdings
Q2 2026- RLMD17.41%
- CCCC11.51%
- COGT11.46%
- KOD6.67%
- RLAY6.21%
- ZNTL6.14%
- EWTX4.03%
- MAZE3.42%
- IVA3.15%
- ANL3.01%
Share classes counted separately73.01%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- CCCCWeight increased · +9.14 pp2.37% → 11.51%Shares +4.95M (+220.00%)
- RLMDWeight decreased · -6.19 pp23.60% → 17.41%Shares -1.12M (-13.27%)
- RLAYWeight increased · +3.53 pp2.68% → 6.21%Shares +297.50K (+44.24%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 25
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | RLMDRELMADA THERAPEUTICS INC View history and evidence | $50.86M | 17.41% | 7.35M shares | 23.60% → 17.41%-6.19 pp -1.12M (-13.27%) | Reduced | ▾ |
| 02 | CCCCC4 THERAPEUTICS INCCOM STK View history and evidence | $33.62M | 11.51% | 7.20M shares | 2.37% → 11.51%+9.14 pp +4.95M (+220.00%) | Added | ▾ |
| 03 | COGTCOGENT BIOSCIENCES INC View history and evidence | $33.48M | 11.46% | 865.00K shares | 12.13% → 11.46%-0.67 pp +77.51K (+9.84%) | Added | ▾ |
| 04 | KODKODIAK SCIENCES INC View history and evidence | $19.48M | 6.67% | 500.00K shares | 5.80% → 6.67%+0.87 pp +120.00K (+31.58%) | Added | ▾ |
| 05 | RLAYRELAY THERAPEUTICS INC View history and evidence | $18.15M | 6.21% | 970.00K shares | 2.68% → 6.21%+3.53 pp +297.50K (+44.24%) | Added | ▾ |
| 06 | ZNTLZENTALIS PHARMACEUTICALS INC View history and evidence | $17.95M | 6.14% | 3.70M shares | 3.40% → 6.14%+2.74 pp +69.00K (+1.90%) | Added | ▾ |
| 07 | EWTXEDGEWISE THERAPEUTICS INC View history and evidence | $11.78M | 4.03% | 290.00K shares | 4.41% → 4.03%-0.38 pp -60.00K (-17.14%) | Reduced | ▾ |
| 08 | MAZEMAZE THERAPEUTICS INC View history and evidence | $10.00M | 3.42% | 335.00K shares | 3.08% → 3.42%+0.34 pp +77.50K (+30.10%) | Added | ▾ |
| 09 | IVAINVENTIVA SA - ADRADS View history and evidence | $9.20M | 3.15% | 2.44M shares | 1.19% → 3.15%+1.96 pp +1.90M (+355.14%) | Added | ▾ |
| 10 | ANLADLAI NORTYE GROUP LTDSPONSORED ADS View history and evidence | $8.80M | 3.01% | 764.88K shares | 3.50% → 3.01%-0.49 pp -500.36K (-39.55%) | Reduced | ▾ |
Options overlay 9
$30.16M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
AVBPARRIVENT BIOPHARMA INC View history and evidence | Call | 183.00K | $6.36M | +73.00K (+66.36%) | ▾ |
BIOABIOAGE LABS INC View history and evidence | Call | 250.00K | $6.13M | +250.00K | ▾ |
RZLTREZOLUTE INCCOM NEW View history and evidence | Call | 900.00K | $4.68M | +900.00K | ▾ |
3 / 9 options · preview only
Exited positions 17
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| KALV KALVISTA PHARMACEUTICALS INC | Non-derivative | -985,100 | -$19.83M | SEC filing ↗ | SEC filing ↗ |
| ABVX ABIVAX SA-ADR | Non-derivative | -130,000 | -$14.48M | SEC filing ↗ | SEC filing ↗ |
| NKTR NEKTAR THERAPEUTICS | Non-derivative | -125,000 | -$8.99M | SEC filing ↗ | SEC filing ↗ |
3 / 17 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 2050709 · Period 2026-06-30
Data loaded 2026-09-23 · First reported 2026-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 322245820
}Research all 43 reported holdings.
This page includes 30 of 43 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 43 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"2050709","quarter":"2026Q2","page_size":100}
get_institutional_manager_history
{"cik":"2050709","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.